Indeed, the increased risk of AD from genetic alterations in retromer‐dependent signaling (e.g., SORL1, VPS26, VPS35) is thought to involve this mechanism, by which “endosomal traffic jams” increase APP time spent in endosomes where it is cleaved to Aβ.50 This evidence concerns the gene VPS26A and Alzheimer disease.